{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,23]],"date-time":"2025-06-23T11:25:45Z","timestamp":1750677945478},"reference-count":19,"publisher":"Oxford University Press (OUP)","issue":"Supplement_3","license":[{"start":{"date-parts":[[2022,12,2]],"date-time":"2022-12-02T00:00:00Z","timestamp":1669939200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,8,18]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Purpose<\/jats:title>\n                  <jats:p>In hypertensive urgency, guidelines recommend oral antihypertensives, but with limited guidance on implementation. The objective of this study was to determine whether time to initiation of oral antihypertensives impacts blood pressure (BP) reduction in patients with hypertensive urgency.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>A descriptive study was conducted of adult hospitalized patients with hypertensive urgency from November 2018 through November 2021. Patients with a systolic BP (SBP) of 180 mm Hg or higher or a diastolic BP (DBP) of 120 mm Hg or higher and receipt of oral antihypertensives within 48 hours of presentation were included. The primary outcome was the percentage change in SBP from baseline at 12 to 24 hours and 24 to 48 hours. Secondary outcomes included the change in DBP and mean arterial pressure (MAP), time to 3 consecutive goal SBP readings, continuation of home oral antihypertensives, administration of intravenous (IV) antihypertensives, and length of stay (LOS). Patients were stratified by quartile (Q1 through Q4) based on time to first oral antihypertensive.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>A total of 220 patients were included. A significant difference in SBP was observed among the quartiles, due to the greater sustained SBP reduction in Q1 at 12 to 24 hours and 24 to 48 hours (median [interquartile range, IQR], 22.9% [13.1%-30.5%] and 22.5% [IQR, 15.8%-32.9%] reduction, respectively). There were also reductions in DBP and MAP, with Q1 consistently having larger reductions than Q4. Patients in Q1 had 3 consecutive goal SBP readings earlier than those in the other quartiles (median [IQR], 13.1 [7.0-21.5] hours). Continuation of home medications, number of IV antihypertensives, and LOS did not differ among the quartiles.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>In this analysis, earlier administration of oral antihypertensives was associated with a larger sustained reduction in SBP.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/ajhp\/zxac357","type":"journal-article","created":{"date-parts":[[2022,12,2]],"date-time":"2022-12-02T00:22:41Z","timestamp":1669940561000},"page":"S85-S96","source":"Crossref","is-referenced-by-count":2,"title":["Initiation of oral antihypertensives in hospitalized patients with hypertensive urgency: A descriptive study"],"prefix":"10.1093","volume":"80","author":[{"given":"Hannah","family":"Chun","sequence":"first","affiliation":[{"name":"Massachusetts General Hospital , Boston, MA , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David E","family":"Zimmerman","sequence":"additional","affiliation":[{"name":"UPMC Mercy Hospital , Pittsburgh, PA"},{"name":"Division of Pharmacy Practice, Duquesne University School of Pharmacy , Pittsburgh, PA , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jordan R","family":"Covvey","sequence":"additional","affiliation":[{"name":"Division of Pharmaceutical, Social, and Administrative Sciences, Duquesne University School of Pharmacy , Pittsburgh, PA , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Branden D","family":"Nemecek","sequence":"additional","affiliation":[{"name":"UPMC Mercy Hospital , Pittsburgh, PA"},{"name":"Division of Pharmacy Practice, Duquesne University School of Pharmacy , Pittsburgh, PA , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2022,12,2]]},"reference":[{"issue":"6","key":"2023081818070517100_CIT0001","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.jash.2011.07.002","article-title":"Intravenous hydralazine for blood pressure management in the hospitalized patient: its use is often unjustified","volume":"5","author":"Campbell","year":"2011","journal-title":"J Am Soc Hypertens"},{"issue":"17","key":"2023081818070517100_CIT0002","first-page":"e484","article-title":"2017 ACC\/AHA\/AAPA\/ABC\/ACPM\/AGS\/APhA\/ASH\/ASPC\/NMA\/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines","volume":"138","author":"Whelton","year":"2018","journal-title":"Circulation"},{"issue":"19","key":"2023081818070517100_CIT0003","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1056\/NEJMcp1901117","article-title":"Acute severe hypertension","volume":"381","author":"Peixoto","year":"2019","journal-title":"N Engl J Med"},{"issue":"1","key":"2023081818070517100_CIT0004","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1093\/ehjcvp\/pvy032","article-title":"ESC Council on Hypertension position document on the management of hypertensive emergencies","volume":"5","author":"van den Born","year":"2019","journal-title":"Eur Heart J Cardiovasc Pharmacother"},{"issue":"2","key":"2023081818070517100_CIT0005","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1177\/000313481207800247","article-title":"As-needed antihypertensive therapy in surgical patients, why and how: challenging a paradigm","volume":"78","author":"Miller","year":"2012","journal-title":"Am Surg"},{"issue":"3","key":"2023081818070517100_CIT0006","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1002\/jhm.2510","article-title":"As-needed intravenous antihypertensive therapy and blood pressure control","volume":"11","author":"Lipari","year":"2016","journal-title":"J Hosp Med"},{"issue":"1","key":"2023081818070517100_CIT0007","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1177\/1753944717746613","article-title":"Retrospective review of the use of as-needed hydralazine and labetalol for the treatment of acute hypertension in hospitalized medicine patients","volume":"12","author":"Gaynor","year":"2018","journal-title":"Ther Adv Cardiovasc Dis"},{"issue":"9","key":"2023081818070517100_CIT0008","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1111\/j.1751-7176.2008.00001.x","article-title":"Hypertensive urgencies in the emergency department: evaluating blood pressure response to rest and to antihypertensive drugs with different profiles","volume":"10","author":"Grassi","year":"2008","journal-title":"J Clin Hypertens"},{"issue":"7","key":"2023081818070517100_CIT0009","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1097\/HJH.0000000000001340","article-title":"Comparing the clinical efficacy of resting and antihypertensive medication in patients of hypertensive urgency: a randomized, control trial","volume":"35","author":"Park","year":"2017","journal-title":"J Hypertens"},{"issue":"3","key":"2023081818070517100_CIT0010","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1177\/106002809402800311","article-title":"Oral antihypertensives for hypertensive urgencies","volume":"28","author":"Gales","year":"1994","journal-title":"Ann Pharmacother"},{"issue":"6","key":"2023081818070517100_CIT0011","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1590\/S1516-31802009000600009","article-title":"Oral drugs for hypertensive urgencies: systematic review and meta-analysis","volume":"127","author":"Souza","year":"2009","journal-title":"Sao Paulo Med J"},{"key":"2023081818070517100_CIT0012","doi-asserted-by":"crossref","first-page":"333","DOI":"10.2147\/OAEM.S275799","article-title":"Immediate prescription of oral antihypertensive agents in hypertensive urgency patients and the risk of revisits with elevated blood pressure","volume":"12","author":"Sricharoen","year":"2020","journal-title":"Open Access Emerg Med"},{"issue":"3","key":"2023081818070517100_CIT0013","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1001\/jamainternmed.2020.7501","article-title":"Treatment and outcomes of inpatient hypertension among adults with noncardiac admissions","volume":"181","author":"Rastogi","year":"2021","journal-title":"JAMA Intern Med"},{"key":"2023081818070517100_CIT0014","article-title":"Hypertensive urgency","volume-title":"StatPearls [proprietary data]","author":"Alley","year":"2022"},{"key":"2023081818070517100_CIT0015","article-title":"Hypotension","volume-title":"StatPearls [proprietary data]","author":"Sharma","year":"2022"},{"issue":"5","key":"2023081818070517100_CIT0016","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1093\/intqhc\/mzt044","article-title":"Missed medication doses in hospitalised patients: a descriptive account of quality improvement measures and time series analysis","volume":"25","author":"Coleman","year":"2013","journal-title":"Int J Qual Health Care"},{"issue":"7","key":"2023081818070517100_CIT0017","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1310\/hpj4907-591","article-title":"Missing doses: a system at fault","volume":"49","author":"O\u2019Neil","year":"2014","journal-title":"Hosp Pharm"},{"issue":"19","key":"2023081818070517100_CIT0018","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1001\/jama.289.19.2560","article-title":"The seventh report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report","volume":"289","author":"Chobanian","year":"2003","journal-title":"JAMA"},{"issue":"8","key":"2023081818070517100_CIT0019","doi-asserted-by":"crossref","first-page":"e008439","DOI":"10.1161\/JAHA.117.008439","article-title":"Evaluation of acute kidney injury and mortality after intensive blood pressure control in patients with intracerebral hemorrhage","volume":"7","author":"Burgess","year":"2018","journal-title":"J Am Heart Assoc"}],"container-title":["American Journal of Health-System Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ajhp\/advance-article-pdf\/doi\/10.1093\/ajhp\/zxac357\/48447213\/zxac357.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ajhp\/article-pdf\/80\/Supplement_3\/S85\/51146830\/zxac357.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ajhp\/article-pdf\/80\/Supplement_3\/S85\/51146830\/zxac357.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,18]],"date-time":"2023-08-18T19:40:22Z","timestamp":1692387622000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajhp\/article\/80\/Supplement_3\/S85\/6862123"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,2]]},"references-count":19,"journal-issue":{"issue":"Supplement_3","published-online":{"date-parts":[[2022,12,2]]},"published-print":{"date-parts":[[2023,8,18]]}},"URL":"https:\/\/doi.org\/10.1093\/ajhp\/zxac357","relation":{},"ISSN":["1079-2082","1535-2900"],"issn-type":[{"value":"1079-2082","type":"print"},{"value":"1535-2900","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2023,9,1]]},"published":{"date-parts":[[2022,12,2]]}}}